MedPath
HSA Approval

FEDAC SYRUP

SIN03193P

FEDAC SYRUP

FEDAC SYRUP

June 1, 1989

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Therapeutic

Pharmacy Only

Formulation Information

SYRUP

**RECOMMENDED DOSAGE:** Syrup:Adults and children over 12 years : 2 teaspoonfuls 3 times a day.Children:6 – 12 years : 1 teaspoonful, 2 – 5 years : ½ teaspoonful. Doses to be taken 3 times a day.Note : 1 teaspoonful is equal to 5ml.

ORAL

Medical Information

**INDICATIONS:** Symptomatic treatment of nasal and respiratory congestion, common cold, acute sinusitis, allergic rhinitis.

**CONTRAINDICATIONS:** Individuals who are hypersensitive to any component in this product, patients with severe hypertension or severe coronary artery disease; patients who are taking or have taken MAOis within the preceding 2 weeks; patients with hyperthyroidism.

R01BA52

pseudoephedrine, combinations

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PT ACTAVIS INDONESIA

Active Ingredients

PSEUDOEPHEDRINE HCl

30 mg/5 ml

Pseudoephedrine

TRIPROLIDINE HCl

1.25 mg/5 ml

Triprolidine

Documents

Package Inserts

Att 8 AAAM7163 Fedac Syrup PIL - Singapore_02 prop.pdf

Approved: February 3, 2021

Download
© Copyright 2025. All Rights Reserved by MedPath